Skip to main content
. 2019 Sep 11;14(9):e0222169. doi: 10.1371/journal.pone.0222169

Table 4. Incidence rates and hazard ratios of acute pancreatitis among kidney transplantation patients stratified by treatment.

Variables N Event Person-years Rate# Crude HR (95% CI) Adjusted HR (95% CI)
Steroid
No 5027 52 33007 1.58 1(Reference) 1(Reference)
Yes 209 2 1433 1.40 0.89(0.22, 3.64) 0.83(0.19, 3.65)
Tacrolimus
No 2348 28 18747 1.49 1(Reference) 1(Reference)
Yes 2888 26 15692 1.66 1.05(0.61, 1.81) 1.01(0.41, 2.47)
Cyclosporin
No 2691 25 14627 1.71 1(Reference) 1(Reference)
Yes 2545 29 19812 1.46 0.90(0.52, 1.56) 0.86(0.36, 2.03)
Sirolimus
No 4725 50 31633 1.58 1(Reference) 1(Reference)
Yes 511 4 2807 1.43 0.88(0.32, 2.46) 0.80(0.28, 2.29)
Mycophenolatemofetil
No 1645 21 12104 1.73 1(Reference) 1(Reference)
Yes 3591 33 22335 1.48 0.83(0.48, 1.44) 0.71(0.39, 1.29)
Certican
No 5233 54 34456 1.57 1(Reference) 1(Reference)
Yes 3 0 3 0.00 - -
Thymoglobulin
No 5114 53 33856 1.57 1(Reference) 1(Reference)
Yes 122 1 583 1.71 1.05(0.15, 7.57) 1.15(0.16, 8.39)

Rate#, incidence rate, per 1,000 person-years; Crude HR, relative hazard ratio; Variables found to be statistically significant in the univariable model were further included in the multivariable model.

Adjusted for alcohol-related illness, gall stone, HCV, and diabetes.

HHS Vulnerability Disclosure